GAMCO Investors’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
GAMCO Investors's BMY Position: Q2 2026 in Review
GAMCO Investors reduced its Bristol-Myers Squibb (BMY) stake by 5% in Q2 2026, selling an estimated $252K and leaving 82,671 shares worth $4.76M. The position accounts for 0.04% of the portfolio, ranked #374.
GAMCO Investors first reported a position in BMY in Q2 2013 and has held it in 53 quarters since. The position peaked at $45.6M in Q2 2016. 2,523 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- GAMCO Investors held 82,671 shares of Bristol-Myers Squibb worth $4.76M as of Q2 2026.
- GAMCO Investors sold 4,387 Bristol-Myers Squibb shares in Q2 2026, an estimated $252K.
- Bristol-Myers Squibb made up 0.04% of GAMCO Investors's portfolio in Q2 2026, its #374 holding.
- GAMCO Investors first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 53 quarters since.
- GAMCO Investors's Bristol-Myers Squibb position peaked at $45.6M in Q2 2016.
- 2,523 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on GAMCO Investors's 13F filing for Q2 2026, filed 12 Aug 2026.